A possible overestimation of the effect of aspirin [11]

Archives of Internal Medicine

Volumn 167, Issue 21, 2007, Pages 2372-2373

  Snoep, Jaapjan D ^a   Dekkers, Olaf M ^b   Vandenbroucke, Jan P ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

CLINICAL TRIAL; DRUG EFFECT; DRUG USE; FOLLOW UP; HEADACHE; HUMAN; LETTER; LIFESTYLE; MORTALITY; MUSCULOSKELETAL PAIN; PRIORITY JOURNAL; RISK FACTOR;

EID: 36549052089     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.21.2372-b     Document Type: Letter

References (5)

1. Chan AT, Manson JE, Feskanich D, Stampfer MJ, Colditz GA, Fuchs CS. Long-term aspirin use and mortality in women. Arch Intern Med. 2007;167(6):562-572.
2. Baron JA. Can aspirin keep mortality at bay? Arch Intern Med. 2007;167(6):535-536.
3. Greenland S, Thomas DC. On the need for the rare disease assumption in case-control studies. Am J Epidemiol. 1982;116(3):547-553.
4. Lubin JH, Gail MH. Biased selection of controls for case-control analyses of cohort studies. Biometrics. 1984;40(1):63-75.
5. Zhang J, Yu KF. What's the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690- 1691.